Artisan Partners
ADPT icon

Artisan Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Artisan Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,022,619
Closed -$120M – 349
2020
Q4 		$120M Sell
2,022,619
-31,363
-2% -$1.62M 0.15% 152
2020
Q3 		$99.9M Sell
2,053,982
-16,796
-0.8% -$706K 0.14% 149
2020
Q2 		$100M Buy
2,070,778
+197,743
+11% +$7.21M 0.16% 141
2020
Q1 		$52M Buy
+1,873,035
New +$52.2M 0.11% 176

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners's ADPT Position: Q1 2021 in Review

Artisan Partners sold out of Adaptive Biotechnologies (ADPT) in Q1 2021, closing a stake of 2,022,619 shares — an estimated $120M sold.

Artisan Partners first reported a position in ADPT in Q1 2020 and held it in 4 quarters. The position peaked at $120M in Q4 2020. 249 funds tracked by Wall St. Rank hold ADPT as of Q1 2021.

  • Artisan Partners reported no remaining Adaptive Biotechnologies position as of Q1 2021 after selling out during the quarter.
  • Artisan Partners sold 2,022,619 Adaptive Biotechnologies shares in Q1 2021, an estimated $120M.
  • Artisan Partners first reported a position in Adaptive Biotechnologies in Q1 2020 and held it in 4 quarters.
  • Artisan Partners's Adaptive Biotechnologies position peaked at $120M in Q4 2020.
  • 249 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2021.

Based on Artisan Partners's 13F filing for Q1 2021, filed 11 May 2021.